Evaluating Teva (NYSE:TEVA) Valuation After FDA Expands UZEDY Approval to Bipolar I Disorder

Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed ...